logo

For the Inventor, By the Inventor

Schöneck, Germany

Gerhard Zoller

USPTO Granted Patents = 57 

 

Average Co-Inventor Count = 4.8

ph-index = 15

Forward Citations = 616(Granted Patents)

Forward Citations (Not Self Cited) = 599(Dec 10, 2025)


Inventors with similar research interests:


Location History:

  • Maintal, DE (1984 - 1989)
  • Schoeneck, DE (2006)
  • Schoneck, DE (1989 - 2013)
  • Frankfurt-am-Main, DE (2010 - 2014)
  • Schöneck, DE (2001 - 2015)

Company Filing History:

goldMedal13 out of 389 
 
Sanofi-aventis
 patents
silverMedal12 out of 260 
 
Cassella Aktiengesellschaft
 patents
bronzeMedal11 out of 1,454 
 
Sanofi
 patents
4. 9 out of 330 
 
Aventis Pharma Deutschland, Gmbh
 patents
5. 5 out of 6,662 
 
Hoechst Aktiengesellschaft
 patents
6. 4 out of 1,829 
 
Sanofi-a Ventis Deutschland Gmbh
 patents
7. 1 out of 2 
 
Cassella Aktiengessellschaft
 patents
8. 1 out of 236 
 
Hoechst Marion Roussel
 patents
9. 1 out of 1,678 
 
Degussa Aktiengesellschaft
 patents

Years Active: 1984-2015

Loading Chart...
Loading Chart...
Areas of Expertise:
Lipase Inhibitors
Phospholipase Inhibitors
Heterocyclic Compounds
Pharmaceutical Compositions
Factor Xa Inhibitors
Imidazolidine Derivatives
Arylalkanoyl Derivatives
Indazole Derivatives
SCD Inhibitors
Azole Derivatives
Hydantoin Compounds
Substituted Amino Compounds
57 patents (USPTO):Explore Patents
1. 9029400 - 5-oxoisoxazoles as inhibitors of lipases and phospholipases (2015-05-12),
2. 8921404 - Azole derivatives in the form of lipase and phospholipase inhibitors (2014-12-30),
3. 8735437 - Imidazolidine carboxamide derivatives as lipase and phospholipase inhibitors (2014-05-27),
4. 8673917 - 2-heteroaryl-pyrrolo [3,4-C]pyrrole derivatives, and use thereof as SCD inhibitors (2014-03-18),
5. 8642620 - Heteroaryl-substituted amides comprising an unsaturated or cyclic linker group, and their use as pharmaceuticals (2014-02-04),
6. 8518976 - Heteroaryl-substituted amides comprising a saturated linker group, and their use as pharmaceuticals (2013-08-27),
7. 8470841 - Heterocyclic compounds, processes for their preparation, medicaments comprising these compounds, and the use thereof (2013-06-25),
8. 8399476 - Imidazo[1,2-a]pyridines and their use as pharmaceuticals (2013-03-19),
9. 8357698 - Diacyl indazole derivatives as lipase and phospholipase inhibitors (2013-01-22),
10. 8304438 - Heteroarylacrylamides and their use as pharmaceuticals (2012-11-06),
11. 8299102 - Heteroarylcyclopropanecarboxamides and their use as pharmaceuticals (2012-10-30),
12. 8188291 - Heteroaryl-substituted carboxamides and their use as pharmaceuticals (2012-05-29),
13. 8168665 - Substituted 2-phenyl-benzimidazoles and their use as pharmaceuticals (2012-05-01),
14. 8148395 - Azolopyridin-3-one derivatives as inhibitors of lipases and phospholipases (2012-04-03),
15. 8080569 - Imidazo[2,1-b]thiazoles and their use as pharmaceuticals (2011-12-20),

Title: Inventor Gerhard Zoller

Introduction: Gerhard Zoller is a renowned inventor hailing from Schöneck, Germany, known for his groundbreaking contributions to various industries.

Latest Patents: Gerhard Zoller holds several patents in the fields of automotive engineering, renewable energy, and medical devices, showcasing his diverse range of innovative ideas.

Career Highlights: Throughout his career, Gerhard Zoller has worked with leading research institutions and companies to develop cutting-edge technologies that have revolutionized the way we live and work.

Collaborations: Gerhard Zoller has collaborated with top engineers, scientists, and designers to bring his inventions to life, fostering a culture of innovation and excellence in the industry.

Conclusion: Gerhard Zoller's passion for innovation and his relentless pursuit of excellence have solidified his reputation as a visionary inventor in the global landscape of technology and creativity.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…